During the past decade, Vinmec Research Institute of Stem Cell and Gene Technology conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vinmec Research Institute of Stem Cell and Gene Technology" #1 collaborator was "National Hospital for Tropical Diseases, Hanoi, Vietnam" with 2 trials as a collaborator, "National Institute of Hematology and Blood Transfusion, Vietnam" with 2 trials as a collaborator, "National Institute of Hygiene and Epidemiology, Vietnam" with 2 trials as a collaborator, "Gwoxi Stem cell applied technology Company" with 1 trials as a collaborator and "Number 2 Children's Hospital, Ho Chi Minh City" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Vinmec Research Institute of Stem Cell and Gene Technology" are "COVID 19" (2 trials), "Autism Spectrum Disorder" (1 trials), "Biliary Atresia" (1 trials), "Bronchopulmonary Dysplasia" (1 trials) and "Cerebral Palsy" (1 trials). Many other conditions were trialed in "Vinmec Research Institute of Stem Cell and Gene Technology" in a lesser frequency.

Most popular intervention types in "Vinmec Research Institute of Stem Cell and Gene Technology" are "Combination Product" (11 trials), "Biological" (9 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Stem cell transplantation" (3 trials), "Autologous BMMC transplantation" (2 trials), "Autologous BMMNCs transplantation and educational intervention" (1 trials), "Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency" (1 trials) and "Autologous bone marrow mononuclear cell transplantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vinmec Research Institute of Stem Cell and Gene Technology" are 18 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vinmec Research Institute of Stem Cell and Gene Technology". 1 are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Vinmec Research Institute of Stem Cell and Gene Technology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vinmec Research Institute of Stem Cell and Gene Technology, 14 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".